Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Entrada Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +14 vs. Q3 2022
- Shares held
- 24.7M
- +198.6K (+0.8%) vs. Q3 2022
- Total value
- $334.2M
- −$52.2M (−13.5%) vs. Q3 2022
- New holders
- 17
- 16 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 4,865,819 | $65.8M | 0.40% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,425,784 | $59.8M | 25.04% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 4,408,379 | $59.6M | 16.02% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,014,377 | $40.8M | 0.01% | +42,327+1.4% | Added |
| Redmile Group, LLC | 1,854,108 | $25.1M | 1.03% | −100,311−5.1% | Reduced |
| Wellington Management Group LLP | 1,010,351 | $13.7M | 0.00% | +3,105+0.3% | Added |
| Vanguard Group Inc | 920,253 | $12.4M | 0.00% | +50,106+5.8% | Added |
| StepStone Group LP | 761,277 | $10.3M | 1.35% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 584,955 | $7.91M | 1.40% | −57,234−8.9% | Reduced |
| 72 Investment Holdings, LLC | 509,023 | $6.88M | 3.16% | 00.0% | Unchanged |
| FMR LLC | 503,911 | $6.81M | 0.00% | +40.0% | Added |
| Goldman Sachs Group Inc | 402,039 | $5.44M | 0.00% | −47,954−10.7% | Reduced |
| Laurion Capital Management LP | 199,066 | $2.69M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 187,994 | $2.54M | 0.00% | +40,401+27.4% | Added |
| Geode Capital Management, LLC | 181,957 | $2.46M | 0.00% | +14,839+8.9% | Added |
| Susquehanna International Group, LLP | 111,797 | $1.51M | 0.00% | +111,797 | New |
| Moore Capital Management, LP | 105,000 | $1.42M | 0.04% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 88,970 | $1.20M | 0.00% | +1,111+1.3% | Added |
| Nan Fung Group Holdings Ltd | 73,582 | $994.8K | 0.69% | −68,011−48.0% | Reduced |
| State Street Corp | 64,523 | $872.4K | 0.00% | +31,229+93.8% | Added |
| TD Asset Management Inc | 59,627 | $806.2K | 0.00% | +131+0.2% | Added |
| Citigroup Inc | 51,042 | $690.1K | 0.00% | +49,459+3,124.4% | Added |
| Manufacturers Life Insurance Company, The | 41,206 | $581.5K | 0.00% | +31+0.1% | Added |
| Millennium Management LLC | 39,894 | $539.0K | 0.00% | +39,894 | New |
| Northern Trust Corp | 34,360 | $464.5K | 0.00% | +4,363+14.5% | Added |
| Swiss National Bank | 26,500 | $358.3K | 0.00% | +26,500 | New |
| Natixis | 26,186 | $354.0K | 0.00% | +26,186 | New |
| Morgan Stanley | 24,886 | $336.5K | 0.00% | +14,356+136.3% | Added |
| Qube Research & Technologies Ltd | 16,782 | $226.9K | 0.00% | +16,782 | New |
| Jane Street Group, LLC | 14,524 | $196.4K | 0.00% | +14,524 | New |
| Ergoteles LLC | 14,019 | $189.5K | 0.01% | +14,019 | New |
| Bank of New York Mellon Corp | 12,439 | $168.2K | 0.00% | +12,439 | New |
| Balyasny Asset Management LLC | 12,132 | $164.0K | 0.00% | +12,132 | New |
| State of Wisconsin Investment Board | 10,971 | $148.3K | 0.00% | +10,971 | New |
| Barclays PLC | 10,772 | $145.6K | 0.00% | +9,557+786.6% | Added |
| 683 Capital Management, LLC | 10,355 | $140.0K | 0.01% | +10,355 | New |
| California State Teachers Retirement System | 9,514 | $128.6K | 0.00% | +9,514 | New |
| Credit Suisse AG | 8,811 | $119.1K | 0.00% | +8,811 | New |
| JPMorgan Chase & Co | 7,593 | $103.0K | 0.00% | +7,593 | New |
| Bank of America Corp | 5,296 | $71.6K | 0.00% | +1,330+33.5% | Added |
| Legal & General Group Plc | 2,937 | $39.7K | 0.00% | +2,937 | New |
| UBS Group AG | 1,257 | $17.0K | 0.00% | +1,257 | New |
| Tower Research Capital LLC (TRC) | 447 | $6.00K | 0.00% | −2,061−82.2% | Reduced |
| Cubist Systematic Strategies, LLC | 405 | $5.48K | 0.00% | −600−59.7% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 168 | $2.27K | 0.00% | +3+1.8% | Added |
| Royal Bank of Canada | 28 | $0 | 0.00% | +28 | New |
| Invesco Ltd. | 0 | $0 | 0.00% | −95,209−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −17,955−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −198−100.0% | Sold out |